Drug profile · INN
cevimeline hydrochloride
CEVIMELINE HYDROCHLORIDE
cevimeline hydrochloride (CEVIMELINE HYDROCHLORIDE) is a muscarinic acetylcholine receptor m1 agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — cevimeline hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cevimeline hydrochloride (CEVIMELINE HYDROCHLORIDE) is a muscarinic acetylcholine receptor m1 agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Muscarinic acetylcholine receptor M1 agonist
Primary target: Muscarinic acetylcholine receptor M1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cevimeline hydrochloride?
cevimeline hydrochloride (CEVIMELINE HYDROCHLORIDE) is a muscarinic acetylcholine receptor m1 agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cevimeline hydrochloride?
CEVIMELINE HYDROCHLORIDE is a marketed brand name for cevimeline hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cevimeline hydrochloride?
cevimeline hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.